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T he anticancer drugs 1-β-D-arabinofuranosylcytosine (Ara-C) and daunorubicin (DNR) are widely used in clinical oncology, especially in the treatment of acute leukemia. Although specific biochemical lesions have been associated with Ara-C-and DNR-mediated cytotoxicity, the pathways leading to the induction of apoptosis remain ill-defined. These agents have been shown to induce apoptosis through the activation of a sphingomyelinase (SMase) responsible for the hydrolysis of sphingomyelin (SM) and the generation of ceramide (CER) (1, 2) . The latter acts as a potent apoptosis mediator, triggering several downstream signaling pathways among which the stress-activated protein kinase cascade (MEKK1-SEK1-SAP/JNK) plays a critical role in apoptosis induction (3) (4) (5) . We recently demonstrated that the SMase/JNK pathway triggered by Ara-C, for example, is dependent on the activation and binding of the src kinase Lyn to SMase (1) , corroborating a recent study suggesting an essential role for scr kinase activation in CER signaling (6) .
Drug-induced SMase activation plays a pivotal role in apoptosis signaling, because the absence of CER generation, due to a defect in SMase stimulation, leads to cell resistance (7, 8) . The spacio-temporal organization of these events is unclear. SM, a major constituent of mammalian cell membranes, is found essentially within the plasma membrane and concentrated mostly in its outer leaflet. However, we and others have demonstrated that in response to cytotoxic effectors such as tumor necrosis factor (TNF)-α, SM is hydrolyzed within the plasma membrane inner leaflet (9, 10) . This apparent discrepancy was partially resolved by the study of van Blitterswijk and coworkers, which demonstrated that the CER generated from the plasma membrane SM (initially located in the outer leaflet) gains access to a cytosolic SMase by flipping to the inner leaflet due to phospholipid scrambling (11) . Moreover, we have shown that in the absence of such a hydrolyzable SM pool within the plasma membrane inner leaflet, SMase cannot be activated by cytotoxic effectors such as TNF-α and DNR (12, 13) . Hence one can conclude from these studies that SMase activation is substrate dependent and therefore it is conceivable that spacial SM organization is essential in the initiation of a SMase-dependent apoptotic pathway.
Because the subcellular location of drug-induced SMase activation remains unclear, we focused this study on the possible compartmentalization of SM signaling pools. A model for membrane structure that describes the organization of the lipid microdomains as platforms, the rafts, has been proposed. It has been demonstrated that proteins can selectively be included or excluded from these microdomains, which can serve as relay stations in intracellular signaling (14) . The main forces driving the formation of rafts are lipid-lipid interactions, dependent on the biophysical characteristics of the lipid components. Detergent-insoluble rafts (and caveolae) have been suggested to be the plasma membrane compartments producing CER, because they are enriched in SM (and neutral SMase) (15) (16) (17) (18) (19) , which confers a low-buoyant density in sucrose. Such microdomains have been described in several hematopoietic cells and other cell types and contain selected membrane glycoproteins, such as CD36, a surface receptor molecule involved in signal transduction in both platelets and monocytes (20) , which have been shown to physically associate with src-related protein tyrosine kinases Fyn, Yes, and Lyn (20) . To address whether rafts are implicated in drug-induced apoptosis signaling, we investigated, using subcellular fractionation, the trafficking of the Lyn-SMase cascade in Ara-C-and DNR-treated myeloid leukemic cells (U937).
MATERIALS AND METHODS

Drugs and reagents
Ara-C was obtained from Upjohn (Paris, France) and DNR from the NCI Drug Repository (Bethesda, MD). Antibodies purchased from TEBU Santa Cruz Biotechnology (Le Perray en Yvelines, France) were anti-p53/56 Lyn (clone 44), anti-cathepsin D (clone C-20), and antihMSH2 (clone N-20). Anti-phosphotyrosine was purchased from BD Transduction Laboratories (Heidelberg, Germany), anti-CD36 antibody (clone FA6-152) from Immunotech (Paris, France), anti-cytochrome c from Pharmingen (Heidelberg, Germany), anti-Golgi (clone 58K-9) from Sigma ImmunoChemicals (St. Louis, MO), and anti-Bcl-2 (clone 124) from DAKO (Trappes, France). Silica gel 60 thin-layer chromatography plates were from Merck (Darmstadt, Germany). Aquasafe 300 scintillation cocktail was purchased from the EG&G (Evry, France). All other drugs and reagents were purchased from Sigma Chemical, Carlo Erba (Rueil-Malmaison, France), or Prolabo (Paris, France).
Cell culture
The human myeloblastic cell line U937 obtained from the ATCC (Rockville, MD) was cultured in RPMI 1640 medium at 37°C in 5% CO 2 . Culture medium was supplemented with 10% heatinactivated fetal calf serum (FCS), 2 mM glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin (all from Eurobio, les Ulis, France).
Isolation of membrane microdomains
Rafts were isolated from cells as previously described (21) . For each isolation, 100 × 10 6 cells were washed twice with phosphate-buffered saline (PBS). After treatment with or without the appropriate drugs, cells were pelleted by centrifugation, resuspended in 1 ml of ice-cold MBSbuffered saline (150 mM NaCl, 25 mM 2-(N-morpholino)-ethanesulfonic acid, pH 6.5) containing 1% (w/v) Triton X-100. After 30 min on ice, cells were further homogenized by 10 strokes of a Dounce homogenizer on ice. Ice-cold MBS (1.5 ml) was added and 2 mL of this suspension were mixed with 2 mL of 80% (w/v) sucrose in MBS. This mixture was subsequently loaded under a linear gradient consisting of 8 ml 5-40% (w/v) sucrose in MBS. All solutions contained the following protease inhibitors: 100 µM phenylmethylsulfonylfluoride; 1 mM EDTA; and 1 µM each of aprotinin, leupeptin, and pepstatin A. Gradients were centrifuged in a Beckman SW 41 swinging-rotor at 39000 rpm for 20 h at 4°C. Twelve fractions of 1 ml each were collected (from top to bottom), vortexed, and stored at -80°C. The protein content of both fractions and the total initial cell suspension were measured using bovine serum albumin (BSA) as standard (22) . CD36 was used as a marker of rafts (23) . Detergent-free extraction of rafts was performed by replacing Triton X-100 with 500 mM sodium carbonate, pH 11, and by adding 250 mM sodium carbonate in the MBS/sucrose gradient (24) .
Cholesterol depletion and repletion
Cholesterol depletion was performed by incubating U937 cells (4 × 10 6 cells/ml) for 30 min at 37° C in buffer A (140 mM NaCl, 5 mM KCl, 5 mM KH 2 PO 4 , 1 mM MgSO 4 , 10 mM Hepes, pH 6.5, 5 mM glucose, 0.2% [w/v] BSA, and 10 mM methyl-β-cyclodextrin [MβCD]) (25) . For the cholesterol repletion, cholesterol-depleted U937 cells were centrifuged and resuspended for 30 min at 37°C in a buffer containing cholesterol/MβCD complexes: Cholesterol (200 µl) in CHCl 3 /CH 3 OH (1/2 v/v) was added to a final concentration of 2 mM in 10 ml of buffer A without BSA and containing 5 mM MβCD while stirring at 80°C. The solution was homogenized by sonication (60 kHz, 3× 20 s), filtered through a 0.2µm filter (Millipore), and then maintained at 37°C. U937 cells were washed and used for rafts purification and SMase activity measurements.
For cell viability assays, cells were treated as already described and then replaced in complete RPMI medium before incubation with Ara-C. Apoptosis was quantified by DAPI staining.
Raft-associated neutral SMase stimulation by activated p56 Lyn
The kinase assay was performed on cellular extracts using purified p56 Lyn (Upstate Biotechnology, Lake Placid, NY). In brief, 220 µl of pooled raft fractions was added to 5 µl of p56 Lyn (5 U) and 25 µl of 10× Src kinase reaction buffer (100 mM Tris-HCl, pH 7.2, 125 mM MgCl 2 , 25 mM MnCl 2 , 2 mM EGTA, 0.25 mM Na 3 VO 4 , 2 mM DTT, and 0.2 mM ATP) (26) . After incubation for 10 min at 30°C, the reaction was stopped in liquid nitrogen and this extract was used to measure neutral SMase activity.
Metabolic cell labeling and sphingolipid quantitation
Total cellular SM and CER quantitation was performed by labeling cells to isotopic equilibrium with 1 µCi/ml of [9, 10 -3 H]palmitic acid (53.0 Ci/mmol, Amersham, Les Ulis, France) for 48 h in complete medium as previously described (27) . Cells were then washed and resuspended in complete medium for time-course experiments. Lipids were extracted and resolved by thin-layer chromatography; SM and CER were scraped and quantitated by liquid scintillation spectrometry.
Sphingomyelinase activities
Each fraction (150 µL aliquot) was assayed for the presence of different SMase activities (27) . After a 2-h incubation at 37°C, reactions were terminated by adding 2.5 ml of chloroform/methanol (2:1, v/v). Phases were separated by centrifugation (1000g, 5 min), and the amount of released radioactive phosphocholine was determined by subjecting 700 µl of the upper phase to scintillation counting.
The amount of radiolabeled substrate that was hydrolyzed during an assay never exceeded 10% of the total amount of substrate added. For calculation of the specific activities in total cell homogenates, values were corrected for protein content, reaction time, and specific activity of the substrate.
Western blotting
Each aliquot was subjected for 5 min to denaturation buffer (62.5 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 0.04% bromophenol blue, and 5% mercaptoethanol). The extracts were resolved by electrophoresis in a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto nitrocellulose membrane (Hybond-C, Amersham, Les Ulis, France), blocked with 10% nonfat milk in Tris-buffered saline-Tween 20 (0.1%) at 4°C for 2 h and incubated overnight at 4°C with anti-CD36, anti-p53/56 Lyn, or anti-phosphotyrosine antibody. Bound proteins were detected by enhanced chemiluminescence detection system (Amersham, Les Ulis, France).
Statistics
The Student's t test was performed to evaluate the statistical significance.
RESULTS
Purification and characterization of rafts in U937 cells
Because the objective of this study was to identify the potential role of plasma membrane rafts in Ara-C triggered apoptosis signaling, it was critical to confirm the purity of the isolated microdomains. Therefore, fractionated U937 cells were analyzed for SM content and Western blotted against several organelle markers. As expected, the Triton-insoluble material expressed high levels of SM, which co-migrated on the density gradient with the raft marker CD36 (Fig. 1) , whereas the majority of cellular proteins was recovered in the high-density fractions of the gradient (Fig. 1, insert) . To control for contaminating nonplasma membrane components, aliquots were also blotted for Golgi marker, cytochrome c (mitochondrial marker), Bcl-2 (mitochondrial/endoplasmic reticulum marker), cathepsin D (lysosomal marker), and MSH2 (cytosolic/nucleus marker). All of these markers were detected only in the lower fractions, indicating that the isolated plasma membrane rafts were devoid of contaminating organelle membrane constituents.
Ara-C-and DNR-induced activation of SMase in rafts
To examine whether neutral SMase was activated by Ara-C and DNR in U937 rafts, cells were treated with 40 µM Ara-C for 15 min or with 1 µM DNR for 10 min (corresponding to peak Ara-C-and DNR-triggered SMase stimulation, respectively [1, 27] ) and then lysed in cold Triton X-100 and fractionated on a sucrose density gradient. Both neutral and acid SMase were then analyzed in the low-and high-density part of the gradients (fractions 1-2, and 10-12, respectively) and in the SM-and CD36-enriched rafts (fractions 4-6). We observed basal neutral and acid SMase activity throughout the gradient ( Fig. 2A and 2B) , with significant neutral SMase enrichment in the raft microdomains (79±2 pmol/h.mg fraction protein) compared with both low-(16.4±1.8 pmol/h.mg fraction protein) and high-density (2.8±0.9 pmol/h.mg fraction protein) parts of the gradient. Furthermore, only in rafts did we measure significant neutral SMase activation (>35%) under Ara-C treatment (Fig. 2B) . No significant increase in acid SMase activity was observed under Ara-C treatment. Similar results were observed with DNR (Fig. 2C) . By prelabeling U937 cells with [9, 10 -3 H]palmitic acid to equilibrium for 48 h, before Ara-C or DNR treatment and cell fractionation, we were able to observe that only in the SM-rich raft domains was there significant CER generation (Fig. 3A and 3B ) and SM hydrolysis (Fig.  3A, insert) . In addition, the effects of Ara-C and DNR on raft-associated neutral SMase activity (data not shown) and ceramide generation (Fig. 3C) were also observed using a nondetergent extraction protocol. These results also show that in untreated U937 cells, there was a significant basal concentration of CER in rafts (as reported by others, 19) which was further increased by Ara-C and DNR treatment.
Ara-C-and DNR-induced Lyn translocation into rafts
We have previously shown that the SMase/CER pathway triggered by Ara-C in U937 cells was dependent on the activation and binding of the src kinase Lyn to SMase (1). Therefore, because Ara-C induced SMase activation in rafts, it was essential to show that this correlated with Lyn activation within these same microdomains. As shown in Figure 4A , in untreated U937 cells, Lyn was essentially found in the high-density fractions, with a small constitutive amount observed in the Triton-insoluble fraction. Treatment of U937 cells with 40 µM Ara-C or 1 µM DNR induced a rapid (within 10-15 min) translocation of Lyn from the high-density fractions to the raft domains. Similar results were observed using the murine pro-B lymphoid cell line Ba/F3 (data not shown). Furthermore, pretreatment of U937 cells with the tyrosine kinase inhibitor herbimycin (which has been shown to completely block drug-induced Lyn activation [28, 29] , SMase stimulation, and apoptosis [1] ) not only inhibited Lyn translocation into rafts but displaced the basal Lyn level. Indeed, Ara-C treatment led to a significant increase in tyrosine phosphorylation events in rafts, which was significantly blocked by herbimycin (Fig. 4B) ; and as expected, Ara-C SMase stimulation was inhibited by herbimycin (Fig. 4C ). This suggested that tyrosine phosphorylation of Lyn was necessary for its compartmentalization (and therefore its interaction with SMase) into rafts. Because we have previously demonstrated that Lyn directly interacts with neutral SMase (1), we evaluated whether activated Lyn could stimulate raftassociated neutral SMase activity in an in vitro assay. As shown in Figure 5 , raft-associated neutral SMase activity was significantly increased when incubated in the presence of activated Lyn.
Effect of raft disruption on drug-induced activation of neutral SMase activity, Lyn translocation, and apoptosis
Our results strongly suggest that plasma membrane microdomains are essential constituents in drug-mediated SMase activation and Lyn translocation. We further confirmed this by pretreating U937 cells with the cholesterol-sequestering agent methyl β-cyclodextrin (MβCD) under conditions where it is still possible to isolate rafts but their content in cholesterol and CD36 are dramatically reduced (~50% decrease [data not shown]) (25) . As shown in Figure 6A , the stimulation of raft-associated neutral SMase by Ara-C was completely inhibited in MβCD-treated cells. Furthermore, cholesterol repletion significantly restored neutral SMase activation by Ara-C. Similarly, Ara-C-induced Lyn translocation into rafts was markedly inhibited by cholesterol depletion and completely restored upon repletion (Fig. 6A, insert) . These results demonstrate that SMase activation and Lyn translocation required (and were restricted to) plasma membrane cholesterol-rich microdomains (rafts). To determine the potential role of rafts on drug-induced cell death, we evaluated Ara-C-induced apoptosis under similar conditions. As shown in Figure 6B , 40 µM Ara-C induced 31 ± 3% apoptosis in U937 cells at 6 h. However, after cholesterol depletion Ara-C-induced apoptosis was reduced to only 20 ± 2%, but increased to 29 ± 3% in cholesterol-repleted cells.
DISCUSSION
Two of the most effective agents in the treatment of acute myelogenous leukemia are Ara-C and DNR. Ara-C acts as an analog of the physiologic nucleoside deoxycytidine and has multiple effects on DNA synthesis. Ara-C undergoes phosphorylation in leukemic cells to form AraCTP, which competitively inhibits DNA polymerase α in opposition to the normal substrate deoxycytidine 5'-triphosphate (dCTP). More important, however, than the effects of Ara-C on DNA synthesis is its incorporation into DNA. Once incorporated into DNA, leukemic cells are unable to excise the nucleoside, and the incorporated Ara-C inhibits template function, slowing or terminating chain elongation. The extent of Ara-C-DNA formation correlates with inhibition of DNA synthesis and loss of clonogenic survival (30) . As for the anthracycline DNR, DNA damage can result from the intercalation-induced distortion of the double-helix and/or by stabilization of the cleavable complex formed between DNA and topoisomerase II (31) . DNA damage induced by Ara-C and DNR has also been associated with DNA fragmentation and endonucleolytic cleavage (32) (33) (34) (35) . However, it remains unclear as to how drug-induced DNA damage relates to programmed cell death signaling.
Many studies have demonstrated that both Ara-C and DNR trigger a wide spectrum of intracellular signals, which may contribute, downstream drug-DNA interaction, to modulate cytotoxicity. Among the recognized bioactive molecules in signal transduction, CER has emerged as a potent mediator of apoptosis induced by a diverse number of cytotoxic effectors, including chemotherapeutic agents (3). Initially, Strum and coworkers reported that treatment of HL-60 cells with Ara-C resulted in a time-and dose-dependent increase of CER and diacylglycerol (36). In their study, the authors showed that CER production correlated with neutral SMase activation. In a second study, the stimulatory effect of Ara-C on neutral SMase was also observed in Jurkat, a human T-cell line (37) . We have demonstrated that both Ara-C at 40 µM and DNR at 1 µM (clinically relevant doses) induced in the U937 myeloid cell line, after 6 h of treatment, a loss of cell viability with characteristic apoptotic features (DNA fragmentation and PARP cleavage) (1, 34) . Under these conditions, Ara-C and DNR treatment induced a rapid activation of a neutral SMase within 10 to 15 min with concomitant CER generation. Finally, we also demonstrated that p53/p56 Lyn activation that is required for apoptosis signaling by Ara-C and DNR was requisite for SMase stimulation (1, 38) .
Because src kinases are for the most part associated with the inner surface of the plasma membrane, we decided in this study to investigate the possible implication of rafts in Ara-C and DNR signaling. Rafts are spontaneously formed at the plasma membrane and are characterized as microdomains that are in a gel-like phase, probably due to the chemical interaction between cholesterol and sphingolipids, which are enriched in these membrane compartments (39) . Their biological significance is linked to their ability to act as lateral sorting platforms for various membrane proteins that associate with them, and initiate various cell signaling cascades (40) .
In this study, we show that U937 plasma membrane rafts are highly enriched, as expected in SM, but also in neutral SMase, activity (19) . Furthermore, treatment of U937 cells with Ara-C and DNR induced within 10-15 min significant stimulation of SMase activity, with concomitant CER generation only in the raft fractions.
In light of the observation that both Ara-C and DNR triggered SMase activation and CER generation is sequestered within rafts, we attempted to delineate the spacio-temporal link of these events to that of drug-induced Lyn activation and binding to SMase. Although Lyn signaling has been extensively studied in myeloid-derived cells, the intracellular localization and trafficking of this protein in these cells is not well elucidated. In this study, we demonstrate that Ara-C and DNR treatment leads to Lyn activation and translocation into rafts. Furthermore, these events were blocked by the tyrosine kinase inhibitor herbimycin, thereby inhibiting drug-induced activation of SMase. Finally, by disrupting U937 rafts (using cyclodextrin under condions in which it is still possible to isolate rafts but in which their content in cholesterol and CD36 is significantly decreased), we observed substantial inhibition of Ara-C-triggered SMase stimulation, Lyn translocation, and apoptosis, firmly establishing that raft domains are prerequisite for these events.
It is clearly established that in most cells SM is found essentially within the outer leaflet of the plasma membrane. Present knowledge strongly suggests that under stress-induced apoptosis signaling, a pool of SM becomes accessible to a cytosolic SMase (thereby generating CER) possibly by flipping to the inner leaflet due to phospholipid scrambling (9) (10) (11) . Moreover, the absence of such a hydrolyzable SM pool within the plasma membrane inner leaflet has been associated with resistance to apoptosis (11, 12) . It therefore appears that SMase activation is substrate dependent and that the spacial SM organization within the plasma membrane may be essential for the initiation of a SMase dependent apoptotic pathway. Indeed, it remains to be determined whether and how drug-induced DNA damage alone leads to apoptosis signaling. Indeed, it has been proposed that Ara-C and DNR might modulate several different biochemical targets in lymphocytes that ultimately induce apoptotic death through caspase activation (41) . On one hand, one could speculate (provocatively) that the rapid interphasic cell death by apoptosis (within 6 h) induced by Ara-C and DNR is triggered by a distinct mechanism in which DNA damage plays only a limited role. DNA damage would in this case come into play only in those cells that escape programmed cell death (>24 h). On the other hand, it is possible that the initial drug/DNA interaction (before inducing significant and measurable damage) is in itself sufficient to initiate a cascade of events, which rapidly traverses from the nucleus to the plasma membrane, thereby igniting apoptosis signaling. Pinpointing the identity of the early stress "sensors" remains a crucial piece still missing in deciphering the mechanism of apoptosis signaling by Ara-C, DNR, and other cytotoxic drugs.
In conclusion, in this study, we provide strong evidence that the SM-CER pathway implicated in apoptosis triggered by Ara-C and DNR, through the stimulation of a Lyn-dependent neutral SMase, requires the recruitment of the src kinase in discrete plasma membrane microdomains (rafts). These findings may have important implications, because it is now conceivable that the lack of apoptosis signaling in drug-resistant cells is possibly linked to the absence and/or constitution of rafts. Further investigations are necessary to determine to what extent the compartmentalization of these signaling processes is altered/absent in drug-resistant cells. [9, 10 - 3 H]palmitic acid, were either untreated ( ) or treated ( ) with 40 µM Ara-C for 15 min. Cells were then lysed in cold Triton X-100 and fractionated on a sucrose density gradient. Fractions were analyzed for ceramide content (expressed as the percentage of total ceramide) Insert: SM levels in control ( ) and Ara-C-treated ( ) cells. B) U937 cells, labeled to isotopic equilibrium with [9,10 - 3 H]palmitic acid, were either untreated ( ) or treated ( ) with 40 µM Ara-C for 15 min or ( ) with 1 µM DNR for 10 min. Cells were then lysed in cold sodium carbonate buffer and fractionated on a sucrose density gradient. In each case, raft fractions were then collected and analyzed for CER content. Results are mean of triplicate determinations of a representative experiment (one of three independent experiments) ± SE. *P<0.01. treated with 1 µM DNR or 40 µM Ara-C, with or without preincubation with 5 µg/ml herbimycin A for 4 h. Cells were then lysed in cold Triton X-100 and fractionated on a sucrose density gradient. Aliquots were collected and Western blotted for Lyn expression. In other experiments, U937 cells were either untreated ( ) or treated with 40 µM Ara-C for 15 min without ( ) or with preincubation with 5 µg/ml herbimycin A for 4 h ( ) Pooled raft fractions were then collected and either Western blotted for tyrosine phosphorylated protein expression and analyzed by densitometry (B) or analyzed for neutral SMase activity (C). A and B are representative of three independent experiments, and C is the mean of triplicate determinations of a representative experiment (one of three independent experiments) ± SE. *P<0.01 apoptosis. U937 cells were either untreated ( , ) or cholesterol depleted ( ) followed by repletion ( ) as described in Materials and Methods. Cells were then incubated with 40 µM Ara-C for 15 min, after which cells were lysed in cold Triton X-100 and fractionated on a sucrose density gradient. Aliquots were collected and raft fractions were analyzed for neutral SMase activity (A) and Lyn translocation within raft fractions 4, 5, and 6 (A, insert). Results are mean ±SE of quadruplicate determinations of a representative experiment (one of three independent experiments). *P<0.01. B) U937 cells were treated as described previously and incubated with Ara-C for 6 h, at which time percent apoptosis was evaluated by DAPI staining. Results are mean ±SE of triplicate determinations of a representative experiment (one of three independent experiments). *P<0.01.
